Propiedad y actividad de insiders de Design Therapeutics, Inc. (DSGN): operaciones de insiders, transacciones del Senado y la Cámara de EE. UU. y acciones en circulación. Sigue cómo operan la acción los directivos y los políticos.
Precio
| Precio | $12.51 |
| Capitalización | $781M |
| Bolsa | NASDAQ |
| País | US |
Operaciones Recientes de Insiders
| Fecha | Insider | Tipo | Acciones | Valor |
|---|---|---|---|---|
| 2026-06-09 | George Simeon | A-Award | 30,000 | $316K |
| 2026-06-09 | Schmid John P. | A-Award | 30,000 | $316K |
| 2026-06-09 | LAPPE RODNEY W | A-Award | 30,000 | $316K |
| 2026-06-09 | Gover Justin D. | A-Award | 30,000 | $316K |
| 2026-06-09 | Shapiro David | A-Award | 30,000 | $316K |
| 2026-06-09 | Berger Heather A. | A-Award | 30,000 | $316K |
| 2026-03-31 | Shapiro David | A-Award | 60,000 | $638K |
| 2026-03-31 | Shapiro David | A-Award | 7,500 | $80K |
| 2026-03-31 | Shapiro David | |||
| 2026-01-02 | Storgard Chris | A-Award | 250,000 | $2.3M |
Balance (10 años)
| Año | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| Caja y Equivalentes | $77000 | $2.4M | $298.6M | $26.5M | $21.2M | $22.6M | $16.9M |
| Inversiones a Corto | 0 | $33.7M | $85.5M | $303.9M | $260.6M | $222.9M | $203.0M |
| Cuentas por Cobrar | 0 | $10000 | $110000 | $1.1M | $1.4M | $1.3M | $1.7M |
| Inventario | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Activos Corrientes | $90000 | $36.2M | $385.4M | $335.1M | $284.6M | $248.0M | $223.8M |
| Inmovilizado Material | 0 | $71000 | $5.1M | $5.6M | $4.6M | $3.6M | $2.4M |
| Fondo de Comercio | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Activos Intangibles | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Activos Totales | $90000 | $36.5M | $390.6M | $341.1M | $289.6M | $252.1M | $226.2M |
| Cuentas por Pagar | $2.5M | $1.4M | $1.6M | $3.0M | $1.9M | $2.2M | $2.3M |
| Deuda a Corto | $695000 | 0 | 0 | 0 | 0 | 0 | 0 |
| Pasivos Corrientes | $3.7M | $2.3M | $5.3M | $10.8M | $9.6M | $8.5M | $13.1M |
| Deuda a Largo | 0 | 0 | 0 | 0 | 0 | 0 | $645000 |
| Pasivos Totales | $3.7M | $47.8M | $8.4M | $13.8M | $12.0M | $10.0M | $13.7M |
| Reservas | -$3.6M | -$11.9M | -$47.5M | -$110.8M | -$177.6M | -$227.2M | -$297.0M |
| Patrimonio Neto | -$3.6M | -$11.3M | $382.1M | $327.3M | $277.7M | $242.1M | $212.5M |
| Deuda Total | $695000 | 0 | $3.6M | $3.7M | $3.0M | $2.3M | $1.5M |
| Deuda Neta | $618000 | -$36.1M | -$380.4M | -$326.7M | -$278.7M | -$243.1M | -$218.3M |
| Capital Circulante | -$3.6M | $33.9M | $380.2M | $324.3M | $275.0M | $239.6M | $210.7M |
Salud financiera
| Deuda / Patrimonio | 0.01 |
| Ratio corriente | 18.86 |
Rentabilidad
| Rentabilidad sobre capital | -34.03% |
| Rentabilidad sobre capital invertido | -38.92% |
| Rentabilidad sobre activos | -32.91% |
| Margen bruto | 0.00% |
| Margen operativo | 0.00% |
| Margen neto | 0.00% |
Empresas relacionadas: ALT · ANNX · AURA · DMAC · ENGN · GALT · IMAB
Explorar sector: Healthcare · Biotechnology
Más secciones de DSGN: Resumen · Financieros · Valoración · Estadísticas · Estimaciones · Técnico · Noticias · Eventos
Descubre más: Radar — señales de acciones infravaloradas · Academia de Inversión — aprende a analizar acciones